Am Investment Strategies »

Denali Therapeutics shares owned by Am Investment Strategies

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Am Investment Strategies from 13F filings

Historical chart of Am Investment Strategies investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Am Investment Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Am Investment Strategies

Quarter filed Position value Share count Share price at filing
2023-03-31 $346k 15k 23.02

More positions owned by Am Investment Strategies

Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Ge Aerospace Com New (GE)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Raymond James Financial (RJF)
NVIDIA Corporation (NVDA)
Us Bancorp Del Com New (USB)
Sportradar Group Class A Ord Shs (SRAD)
Southern Company (SO)
Asml Holding N V N Y Registry Shs (ASML)
Apollo Global Mgmt (APO)

View all positions for Am Investment Strategies

Top funds holding Denali Therapeutics

Vanguard Group
Baillie Gifford & Co
BlackRock
FMR
T. Rowe Price Investment Management
Ubs Global Asset Management Americas
State Street Corporation
Temasek Holdings
Capital Research Global Investors
Baker Bros. Advisors
Alliancebernstein
Geode Capital Management
Crestline Management
Holocene Advisors
Point72 Asset Management

View all funds holding Denali Therapeutics